What should I pay attention to when using ritexitinib (Lao version)?
Rituxitinib, a covalent kinase inhibitor, is widely used to treat severe alopecia areata in adults and adolescents aged 12 years and older. Before starting to use ritexitinib (Laos version), be sure to fully communicate with your doctor and provide all important information about your health, including possible diseases, allergies, medications you are taking, and pregnancy or breastfeeding status. This information is crucial for doctors to develop personalized treatment plans.
So, what should we pay attention to when using ritexitinib (Laos version)?
1. Bleeding risk: Ritexitinib may cause a decrease in the number of platelets in the blood and affect wound hemostasis. If you have symptoms such as frequent nosebleeds, unexplained bruising, or black, tarry stools, call your doctor immediately. Your doctor may order routine blood tests to detect and treat potential problems early.
2. Blood clot formation: This drug may increase the risk of thrombosis and affect blood flow to organs or limbs. If you experience symptoms such as severe pain and swelling in your legs, difficulty breathing, chest pain, blurred vision, or difficulty speaking, seek medical attention immediately.
3. Cancer risk: Although rare, patients who take ritexitinib or similar drugs for a long time are at risk of developing cancer, such as lymphoma, non-melanoma skin cancer, and lung cancer. If you are concerned about this, please discuss it further with your doctor.
4. Heart attack and stroke: Ritexitinib may increase the risk of heart attack and stroke, especially in patients with risk factors for heart disease. If you have symptoms such as chest pain, difficulty breathing, pain extending to your shoulder and arm, nausea and vomiting, sweating, weakness on one side of the body, or slurred speech, seek medical attention immediately.
5. Risk of infection: This drug will reduce the body's response to infection and increase the risk of serious infection. If you have a history of exposure to TB, severe or recurring infections, or have medical conditions that may increase your likelihood of infection, discuss this with your doctor in detail. At the same time, avoid contact with people with infectious diseases and seek medical attention immediately if you notice signs of infection.
6. Impact on liver function: Decreased liver function or liver disease may cause drugs to accumulate in the body and produce side effects. If you have a history of liver disease, discuss with your doctor how your medications may affect you and whether you need special monitoring. In particular, people who have had hepatitis B in the past may experience a recurrence of their disease while taking ritexitinib.
7. Vaccination: While taking ritexitinib, some vaccines may not produce the expected effect and should not even be vaccinated. Check with your doctor to find out if any vaccines you plan to receive may conflict with any medications.
8. Pregnancy and breastfeeding: Ritexitinib should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking this medicine, please contact your doctor immediately. People who may become pregnant should use appropriate contraception while taking this medicine and for at least1 month after taking the last dose of medicine. At the same time, it is not known whether the drug passes into breast milk, and nursing women should discuss with their doctor whether to continue breastfeeding.
9. Use in children: It has not yet been determined The safety and effectiveness of ritixitinib in children under 12 years of age. Therefore, do not give this medication to children without your permission.
10. Allergic reaction: If you are allergic to any active ingredient in ritexitinib capsules, you should not use this drug.
In short, when using ritexitinib (Laos version), patients need to pay close attention to their physical condition and follow the doctor's instructions for medication. During the medication, if you notice any abnormal symptoms, please seek medical treatment immediately and maintain communication with your doctor.
References:
https://medbroadcast.com/drug/getdrug/litfulo
xa0
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)